Clinical use of cerebral oximetry in extremely preterm infants is feasible
Research output: Contribution to journal › Journal article › Research › peer-review
The research programme Safeguarding the Brains of our smallest Children (SafeBoosC) aims to test the benefits and harms of cerebral near-infrared spectroscopy (NIRS) oximetry in infants born before 28 weeks of gestation. In a phase II trial, infants will be randomised to visible cerebral NIRS oximetry with pre-specified treatment guidelines compared to standard care with blinded NIRS-monitoring. The primary outcome is duration multiplied with the extent outside the normal range of regional tissue oxygen saturation of haemoglobin (rStO2) of 55 to 85% in percentage hours (burden). This study was a pilot of the Visible -Oximetry Group.
| Original language | English |
|---|---|
| Journal | Danish Medical Bulletin (Online) |
| Volume | 60 |
| Issue number | 1 |
| Pages (from-to) | A4533 |
| ISSN | 1603-9629 |
| Publication status | Published - 2013 |
ID: 48457058